GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 124 filers reported holding GOSSAMER BIO INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,872,373 | +16.3% | 7,051,360 | +67.6% | 0.00% | +50.0% |
| Q2 2023 | $5,048,492 | +73279.2% | 4,207,077 | -23.0% | 0.00% | -50.0% |
| Q1 2023 | $6,880 | -31.5% | 5,460,380 | +18.0% | 0.00% | -33.3% |
| Q4 2022 | $10,037 | -99.9% | 4,625,511 | +248.0% | 0.01% | -33.3% |
| Q3 2022 | $15,923,000 | +28.5% | 1,329,115 | -10.2% | 0.01% | +12.5% |
| Q2 2022 | $12,394,000 | +267.3% | 1,480,705 | +281.0% | 0.01% | +300.0% |
| Q1 2022 | $3,374,000 | +42.8% | 388,687 | +86.1% | 0.00% | +100.0% |
| Q4 2021 | $2,363,000 | -63.0% | 208,892 | -58.9% | 0.00% | -75.0% |
| Q3 2021 | $6,395,000 | +29.6% | 508,790 | -16.3% | 0.00% | +33.3% |
| Q2 2021 | $4,934,000 | +1191.6% | 607,616 | +1372.6% | 0.00% | – |
| Q1 2021 | $382,000 | -80.0% | 41,262 | -79.1% | 0.00% | -100.0% |
| Q4 2020 | $1,910,000 | -69.7% | 197,514 | -61.1% | 0.00% | -87.5% |
| Q3 2020 | $6,294,000 | +131.7% | 507,184 | +142.7% | 0.01% | +100.0% |
| Q2 2020 | $2,716,000 | +104.8% | 208,959 | +60.0% | 0.00% | +33.3% |
| Q1 2020 | $1,326,000 | -59.4% | 130,635 | -37.4% | 0.00% | -25.0% |
| Q4 2019 | $3,262,000 | +648.2% | 208,681 | +936.4% | 0.00% | +300.0% |
| Q1 2019 | $436,000 | – | 20,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |